Surrey Heartlands

Joint Formulary & PAD

Mupirocin - Nasal staphylococci eradication

You are here : Home > Formulary Search > Mupirocin - Nasal staphylococci eradication

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Nasal ointment
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
2% nasal ointment. Not for routine use in primary care. Follow advice in CKS

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mupirocin
Indication :
Nasal staphylococci eradication
Group Name :
Keywords :
meticillin resistant staphylococcus aureus, MRSA
Brand Names Include :
Bactroban
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Mupirocin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nasal staphylococci eradication.

Committee Recommendations (1)

06 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.